510(k) K023891
K023891 is an FDA 510(k) premarket notification submitted by Tosoh Medics, Inc. for the device "ST AIA-PACK CA 125 ENZYME IMMUNOASSAY". The FDA issued a decision of Substantially Equivalent on December 6, 2002. The device falls under product code LTK (Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)), a Class II device regulated under 21 CFR 866.6010. Tosoh Medics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 6, 2002
- Date Received
- November 22, 2002
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)
- Device Class
- Class II
- Regulation Number
- 866.6010
- Review Panel
- IM
- Submission Type